| Current Price | $65.39 | Mkt Cap | $6.7B |
|---|---|---|---|
| Open | $66.55 | P/E Ratio | 736.23 |
| Prev. Close | $66.31 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $64.57 - $67.09 | Volume | 519,891 |
| 52-Wk Range | $53.40 - $98.84 | Avg. Daily Vol. | 811,763 |
| Current Price | $65.39 | Mkt Cap | $6.7B |
|---|---|---|---|
| Open | $66.55 | P/E Ratio | 736.23 |
| Prev. Close | $66.31 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $64.57 - $67.09 | Volume | 519,891 |
| 52-Wk Range | $53.40 - $98.84 | Avg. Daily Vol. | 811,763 |
The best Bull and Bear pitches based on recency and number of recommendations.
Read the most recent pitches from players about NVCR.
Recs
holdsteady
(69.59)
Submitted: 6/2/2020 11:19:55 AM :
Start Price:
$65.26
NASDAQ:NVCR Score:
-0.70
Market leader in non-invasive cancer therapy, several treatments in phase 3 trials, 40% revenue growth with current treatments.
Recs
BuyouTech
(< 20)
Submitted: 6/1/2020 3:09:42 PM :
Start Price:
$66.38
NASDAQ:NVCR Score:
-2.50
Proven technology that will probably be expanded to treat other types of solid tumors
Recs
tamarabenda
(59.20)
Submitted: 5/31/2020 5:45:30 PM :
Start Price:
$67.00
NASDAQ:NVCR Score:
-4.02
very positive results from phase 3 trials for GBM with potential for positive results for multiple phase 3 trials for non-small cell lung cancer, ovarian cancer and pancreatic cancer that would greatly expand the addressable market. will likely not have any big news until 2022-2023 when results are released.
Find the members with the highest scoring picks in NVCR.
oldlumike (41.80) Score: +471.71
The Score Leader is the player with the highest score across all their picks in NVCR.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
|
stcksrus | 97.66 | 7/27/2016 |
|
5Y | $11.69 | +456.54% | +41.39% | +415.15 | 0 Comment |
| synapse | 97.46 | 10/20/2017 |
|
5Y | $18.25 | +256.49% | +19.63% | +236.86 | 0 Comment | |
| meridius91 | 95.74 | 10/23/2017 |
|
5Y | $18.43 | +253.11% | +19.42% | +233.68 | 1 Comment | |
| SuzyP99 | 82.00 | 8/23/2017 |
|
1Y | $18.75 | +246.99% | +25.69% | +221.30 | 1 Comment | |
|
|
skyrocket29 | 62.60 | 8/22/2017 |
|
1Y | $19.10 | +240.63% | +26.08% | +214.55 | 0 Comment |
| tprooney3 | 96.21 | 7/17/2017 |
|
5Y | $19.25 | +237.97% | +25.10% | +212.87 | 1 Comment | |
| XMFpessen | 92.51 | 12/5/2017 |
|
5Y | $19.95 | +226.20% | +16.21% | +209.99 | 0 Comment | |
| only1ferret | 57.09 | 12/6/2017 |
|
5Y | $20.08 | +224.08% | +16.51% | +207.58 | 0 Comment | |
| kaderoundy | 99.11 | 10/8/2015 |
|
5Y | $17.98 | +261.85% | +54.36% | +207.49 | 0 Comment | |
|
|
ATrain | 83.19 | 12/21/2017 |
|
5Y | $20.25 | +221.28% | +14.70% | +206.59 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
